Blood biomarker may indicate severe cognitive decline progression in Parkinson’s
GBA (a genetic mutation) that leads to not only the early onset of Parkinson’s but also severe cognitive impairment (in 4-7%) also alters how certain things (like lipids) metabolize. Parkinson’s patients who don’t have the gene mutation have higher levels of these lipids in their blood. People who had Parkinson’s and the high levels were more likely to have dementia and cognitive impairment.
http://www.sciencedaily.com/releases/2013/09/130918180120.htm
Related Posts
-
Pets may be linked to slower cognitive decline
Posted on Mar 24, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Hypertension in young adults affects brain later
Posted on Mar 8, 2022
-
Being lonely more often may raise dementia risk
Posted on Mar 3, 2022
Tags
Share This
